Portolan Capital Management’s Supernus Pharmaceuticals SUPN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-18,990	Closed	-$470K	–	137
2016 Q3	$470K	Sell	18,990 -195,794	-91%	-$4.85M	0.06%	109
2016 Q2	$4.38M	Sell	214,784 -46,137	-18%	-$940K	0.63%	62
2016 Q1	$3.98M	Buy	260,921 +78,132	+43%	+$1.19M	0.53%	68
2015 Q4	$2.46M	Buy	+182,789	New	+$2.46M	0.31%	96